ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.840
+0.030 (1.66%)
May 29, 2026, 12:38 PM EDT - Market open
ProKidney Revenue
ProKidney had revenue of $226.00K in the quarter ending March 31, 2026, a decrease of -1.74%. This brings the company's revenue in the last twelve months to $889.00K, up 190.52% year-over-year. In the year 2025, ProKidney had annual revenue of $893.00K with 1,075.00% growth.
Revenue (ttm)
$889.00K
Revenue Growth
+190.52%
P/S Ratio
614.99
Revenue / Employee
$3,848
Employees
231
Market Cap
555.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 893.00K | 817.00K | 1,075.00% |
| Dec 31, 2024 | 76.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MiMedx Group | 389.42M |
| Rigel Pharmaceuticals | 299.77M |
| Gyre Therapeutics | 117.05M |
| Assembly Biosciences | 71.10M |
| Editas Medicine | 38.69M |
PROK News
- 1 day ago - ProKidney Transcript: AGM 2026 - Transcripts
- 14 days ago - ProKidney reports Q1 EPS (14c), consensus (14c) - TheFly
- 14 days ago - ProKidney sees cash runway into mid-2027 - TheFly
- 14 days ago - ProKidney Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 14 days ago - ProKidney Quarterly report: Q1 2026 - Filings
- 14 days ago - ProKidney Earnings release: Q1 2026 - Filings
- 6 weeks ago - ProKidney Proxy statement: Proxy filing - Filings
- 6 weeks ago - ProKidney Proxy statement: Proxy filing - Filings